These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2206 related articles for article (PubMed ID: 27256883)

  • 21. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
    Zheng W
    Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
    Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
    Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.
    Fu BX; Wainberg M; Kundaje A; Fire AZ
    Genetics; 2017 Aug; 206(4):1727-1738. PubMed ID: 28634160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
    East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
    Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
    Liu T; Pan S; Li Y; Peng N; She Q
    Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition.
    Jiang F; Zhou K; Ma L; Gressel S; Doudna JA
    Science; 2015 Jun; 348(6242):1477-81. PubMed ID: 26113724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
    Koo Y; Ka D; Kim EJ; Suh N; Bae E
    J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bacterial Argonaute with noncanonical guide RNA specificity.
    Kaya E; Doxzen KW; Knoll KR; Wilson RC; Strutt SC; Kranzusch PJ; Doudna JA
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4057-62. PubMed ID: 27035975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.
    Meeske AJ; Marraffini LA
    Mol Cell; 2018 Sep; 71(5):791-801.e3. PubMed ID: 30122537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system.
    Nam KH; Haitjema C; Liu X; Ding F; Wang H; DeLisa MP; Ke A
    Structure; 2012 Sep; 20(9):1574-84. PubMed ID: 22841292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
    Sheppard NF; Glover CV; Terns RM; Terns MP
    RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
    Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
    Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-dependent RNA targeting by CRISPR-Cas9.
    Strutt SC; Torrez RM; Kaya E; Negrete OA; Doudna JA
    Elife; 2018 Jan; 7():. PubMed ID: 29303478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble.
    Liu TY; Liu JJ; Aditham AJ; Nogales E; Doudna JA
    Nat Commun; 2019 Jul; 10(1):3001. PubMed ID: 31278272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.
    Westra ER; Semenova E; Datsenko KA; Jackson RN; Wiedenheft B; Severinov K; Brouns SJ
    PLoS Genet; 2013; 9(9):e1003742. PubMed ID: 24039596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the miniature type V-F CRISPR-Cas effector enzyme.
    Takeda SN; Nakagawa R; Okazaki S; Hirano H; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Nishimasu H; Nureki O
    Mol Cell; 2021 Feb; 81(3):558-570.e3. PubMed ID: 33333018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
    Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
    Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 111.